Clinical trials - Press Releases

Date	Title	Company
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization	Carterra, Inc
15-Dec-2020	True Medical Partners with Trulioo to Provide Real-Time Identity Verification During Digital Onboarding and Meet Regulatory Compliance	Trulioo
15-Dec-2020	Imfinzi recommended for approval in the EU by CHMP for less-frequent, fixed-dose use in unresectable non-small cell lung cancer	AstraZeneca
15-Dec-2020	Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030	Sanofi
14-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
14-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
14-Dec-2020	TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy	SAREUM HOLDINGS PLC
14-Dec-2020	ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available	ViiV Healthcare
14-Dec-2020	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	Moberg Pharma
14-Dec-2020	Atox Bio announces FDA acceptance of New Drug Application	Arix Bioscience plc
14-Dec-2020	Emapalumab submission in China for primary HLH	Orphan Biovitrum AB
14-Dec-2020	Novo Holdings Creates New Rare Bleeding Disorder Company, Hemab	Novo Holdings
14-Dec-2020	Trixeo Aerosphere approved in the EU for maintenance treatment of COPD	AstraZeneca
14-Dec-2020	Celltrion Healthcare receives EU CHMP positive opinion for biosimilar adalimumab, CT-P17	Celltrion Healthcare
14-Dec-2020	Grant awarded to Qlucore to aid clinical diagnostics of cancer	Qlucore
14-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
14-Dec-2020	The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials	Russian Direct Investment Fund
10-Dec-2020	University spin-out fund makes half a million pound first investments	Northern Accelerator
10-Dec-2020	European study shows: Poor health literacy a major challenge to self-care[1] with opportunity for pharmacists to play a more prominent role	GSK / GSK Consumer Healthcare